Radius Health Inc logo

RDUS - Radius Health Inc News Story

$12.04 -0.5  -4.1%

Last Trade - 18/09/20

Mid Cap
Market Cap £449.6m
Enterprise Value £517.8m
Revenue £154.5m
Position in Universe 2831st / 6371

BUZZ-Radius Health: Rises on better-than-expected Q2 results

Mon 10th August, 2020 4:22pm
** Drug maker's  RDUS.O  shares rise as much as ~6% to
$12.73 in morning trade
    ** Company posts smaller Q2 loss of 67 cents/share, compared
with analysts' loss expectation of 74 cents/share; product
revenue of $50.1 mln beats estimates of $47.4 mln - Refinitiv
    ** Q2 U.S. net sales of TYMLOS, company's first commercial
product, rose 22% compared with a year earlier  urn:newsml:reuters.com:*:nGNX8bbhCp
    ** Company says enrollment in ATOM Phase 3, which is
assessing the efficacy and safety of abaloparatide-SC in men
with osteoporosis, is expected to complete this week     
    ** Stock down ~38% so far this year

 (Reporting by Shreyasee Raj in Bengaluru)
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.